BTIG analyst Mark A. Massaro reiterated a Sell rating and $0.20 price target on Ginkgo Bioworks Holdings Inc (NYSE: DNA)The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE